artisteer / iStockphoto.com
An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds.
In late July, Europe’s highest court handed down a much-awaited ruling on gene-editing which was met by an uproar from parts of the scientific community.
For Huw Jones, professor of translational genomics for plant breeding at Aberystwyth University in Wales, the EU has essentially “turned back the clock on innovation”. This is unlike many other countries that have signalled that, with certain conditions, gene-edited crops are not be regulated by genetically modified organisms (GMO) laws.
After awaiting regulatory clarification for years, researchers and developers were shocked by the court’s decision to subject genome-editing techniques, including CRISPR/Cas9, to more stringent regulations.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
